Chemed (CHE) Competitors

Chemed (NYSE:CHE) and Medpace (NASDAQ:MEDP) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations.

Which has more risk & volatility, CHE or MEDP?

Chemed has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Comparatively, Medpace has a beta of 1.47, meaning that its share price is 47% more volatile than the S&P 500.

Which has better earnings & valuation, CHE or MEDP?

Medpace has lower revenue, but higher earnings than Chemed. Chemed is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.43B	2.74	$302M	$20.53	22.19
Medpace	$2.16B	4.19	$404.39M	$13.10	24.00

Do analysts recommend CHE or MEDP?

Chemed presently has a consensus price target of $645.00, indicating a potential upside of 41.60%. Medpace has a consensus price target of $344.82, indicating a potential upside of 9.68%. Given Chemed's stronger consensus rating and higher possible upside, equities research analysts plainly believe Chemed is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Medpace	0 Sell rating(s)	11 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.21

Does the media refer more to CHE or MEDP?

In the previous week, Medpace had 12 more articles in the media than Chemed. MarketBeat recorded 21 mentions for Medpace and 9 mentions for Chemed. Chemed's average media sentiment score of 1.01 beat Medpace's score of 0.98 indicating that Chemed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemed	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Medpace	10 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders & institutionals believe in CHE or MEDP?

95.9% of Chemed shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 3.3% of Chemed shares are owned by company insiders. Comparatively, 20.3% of Medpace shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Is CHE or MEDP more profitable?

Medpace has a net margin of 19.31% compared to Chemed's net margin of 12.40%. Medpace's return on equity of 54.36% beat Chemed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	12.40%	27.58%	18.96%
Medpace	19.31%	54.36%	20.81%

Summary

Medpace beats Chemed on 10 of the 16 factors compared between the two stocks.